A randomized, double-blind, placebo- and active-controlled phase III study of tapentadol ER for chronic low back pain: analysis of efficacy endpoint sensitivity
M. Etropolski, C. Rauschkolb-Löffler, D. Shapiro, A. Okamoto, C. LangeVolume:
10
Year:
2009
Language:
english
DOI:
10.1016/j.jpain.2009.01.275
File:
PDF, 36 KB
english, 2009